BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 14, 2001
View Archived Issues
VEGF gene therapy improves clinical status, myocardial perfusion and ischemia in angina
Read More
New treatment regimens of Zithromax recommended for approval in pediatric ear infections
Read More
Preclinical milestone achieved for SignalGene's SERM compounds
Read More
Preclinical results further validate Islet Neogenesis Therapy for diabetes
Read More
Ethics committee approval granted for PI-88 phase II trial in multiple myeloma
Read More
BioSante licenses vaccine technology to Corixa
Read More
Revised phase III plans for Endovasc's NRA and Liprostin
Read More
Traditional medicine used in Korea inhibits behavioral effects of psychostimulants
Read More
AMPA receptor antagonist ER-167288-01 ameliorates neurological status in MS model
Read More
Antioxidant strategy based on targeted enzyme induction may be beneficial in MS
Read More
Preclinical evidence supports the therapeutic potential of dexefaroxan in AD
Read More
Neurochemical effects of selective, oral AChE inhibitor from Chiesi studied in rats
Read More
Lundbeck offers interim progress report
Read More
Factor Xa inhibitor as a novel therapeutic agent in embolic stroke
Read More
New caspase inhibitor limits infarct size in rat model of cardiac ischemia/reperfusion injury
Read More
Prevention of carotid artery intimal hyperplasia by oral chymase inhibitor
Read More
FDA approves frovatriptan for treatment of migraine
Read More
Termination of PSVT with CVT-510 associated with fewer arrhythmias than adenosine
Read More
ImmunoGen highlights Q1 development progress
Read More
Enzyme targets for therapeutic intervention in AD
Read More
Use of growth factor in erectile dysfunction
Read More
Cathepsin K inhibitors and their use described in recent patent
Read More
Treatment of inflammatory and autoimmune diseases with new IL-2 inhibitors
Read More
MethylGene patents new histone deacetylase inhibitors for use in neoplastic diseases
Read More
Pharma Mar identifies novel antitumor compounds from marine sponge
Read More
Acetamide-based thrombin inhibitors synthesized at Merck & Co.
Read More
